- 1Company profiles
- 2Careers
- 3News
At the annual conference of the German Society for Pulmonology (DGP), Dr. Moeller from the HelmholtzZentrum münchen presented the most recent results of his work group on inhalation therapy with the PARI SINUS device and its further development, the PARI Vibrent® device. The fact that the paranasal cavities were so efficiently reached with PARI SINUS and Vibrent® could be attributed to the unique mechanism of operation of these special nebuliser devices, he stated. Only with the pulsation of the aerosol and a slight counter pressure in the second nostril could some of the healing steam penetrate to the site of action – the inflamed paranasal sinuses.
Dr. Moeller also reported on a medical case showing that this therapeutic principle can be extremely beneficial: A patient with persistent chronic sinusitis was already scheduled for surgery. However, aerosol therapy with a PARI SINUS device then resolved the inflammation and the associated symptoms, and surgical intervention was avoided.
According to Dr. Moeller, chronic sinusitis is a very common disorder. He stated that it is estimated that about 10-15% of the European and US population are affected by this disease.
![]() | ![]() |
|---|
Animation: Ventilation studies with the radioactive gas 81m_Kr in front of the gamma camera: left: nasal inhalation without pulsation; right: nasal inhalation with pulsation. By courtesy of the Institute of Lung Biology and Disease (iLBD) at HelmholtzZentrum münchen
Möller, W. et al. (2009) Ventilation and aerosolized drug delivery to the paranasal sinuses using pulsating airflow - a preliminary study. Rhinology 47, 405-412